N-hydroxy-3-(1-((3S,5S)-5-(hydroxymethyl)-1-phenethylpyrrolidin-3-yl)-1H-1,2,3-triazol-4-yl)benzamide

ID: ALA3792705

Chembl Id: CHEMBL3792705

PubChem CID: 137175012

Max Phase: Preclinical

Molecular Formula: C22H25N5O3

Molecular Weight: 407.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NO)c1cccc(-c2cn([C@H]3C[C@@H](CO)N(CCc4ccccc4)C3)nn2)c1

Standard InChI:  InChI=1S/C22H25N5O3/c28-15-20-12-19(13-26(20)10-9-16-5-2-1-3-6-16)27-14-21(23-25-27)17-7-4-8-18(11-17)22(29)24-30/h1-8,11,14,19-20,28,30H,9-10,12-13,15H2,(H,24,29)/t19-,20-/m0/s1

Standard InChI Key:  LIMXAXNNYRTMIA-PMACEKPBSA-N

Alternative Forms

  1. Parent:

    ALA3792705

    ---

Associated Targets(Human)

HDAC11 Tclin Histone deacetylase 11 (967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.47Molecular Weight (Monoisotopic): 407.1957AlogP: 1.91#Rotatable Bonds: 7
Polar Surface Area: 103.51Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.73CX Basic pKa: 9.34CX LogP: 1.64CX LogD: 0.60
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -1.07

References

1. Tian Y, Jin J, Wang C, Lv W, Li X, Che X, Gong Y, Li Y, Li Q, Hou J, Wang PG, Shen J..  (2016)  A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors.,  26  (10): [PMID:27055940] [10.1016/j.bmcl.2016.03.116]

Source